Cocaine use in the U.S. is rising again, accompanied by a troubling increase in overdose deaths due to fentanyl-laced cocaine. Fentanyl, a synthetic opioid 50 times more potent than heroin, significantly heightens the risks associated with cocaine use. Recent surveys show a resurgence in cocaine use, particularly among employed men aged 25 to 45. Mental health clinicians in office-based practice are often the first point of contact for functional adults grappling with cocaine and other substance use issues. As such, it is crucial for therapists—regardless of their specialty or professional background—to be equipped with the knowledge and skills to identify, assess, and treat substance use disorders, and/or to refer patients for specialized care when necessary. Early intervention by clinicians can greatly improve treatment outcomes, mitigating both personal and professional consequences of untreated substance use. In the case of cocaine, timely action can also prevent fentanyl-related overdose deaths. This webinar is designed to enhance participants’ understanding of the distinct features of cocaine and opioids, as well as the clinical considerations that set them apart from other psychoactive substances. It will introduce a set of therapeutic interventions for assessing, motivating, and treating clients with substance use problems in an office-based psychotherapy setting. The approach described is rooted in a client-centered, individualized framework that supports both harm reduction and abstinence goals to optimize treatment engagement, retention, and clinical outcomes. The role of medication-assisted treatment will also be discussed.

Live Zoom Webinar

Instructor: Arnold Washton, PhD

For more information and registration, click here.